Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease. / Degett, Thea Helene; Moustsen-Helms, Ida Rask; Larsen, Signe Benzon; Kjær, Trille Kristina; Tjønneland, Anne; Kjær, Susanne Krüger; Johansen, Christoffer; Gögenur, Ismail; Dalton, Susanne Oksbjerg.

In: Acta Oncologica, Vol. 62, No. 7, 2023, p. 728-736 .

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Degett, TH, Moustsen-Helms, IR, Larsen, SB, Kjær, TK, Tjønneland, A, Kjær, SK, Johansen, C, Gögenur, I & Dalton, SO 2023, 'Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease', Acta Oncologica, vol. 62, no. 7, pp. 728-736 . https://doi.org/10.1080/0284186X.2023.2212844

APA

Degett, T. H., Moustsen-Helms, I. R., Larsen, S. B., Kjær, T. K., Tjønneland, A., Kjær, S. K., Johansen, C., Gögenur, I., & Dalton, S. O. (2023). Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease. Acta Oncologica, 62(7), 728-736 . https://doi.org/10.1080/0284186X.2023.2212844

Vancouver

Degett TH, Moustsen-Helms IR, Larsen SB, Kjær TK, Tjønneland A, Kjær SK et al. Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease. Acta Oncologica. 2023;62(7):728-736 . https://doi.org/10.1080/0284186X.2023.2212844

Author

Degett, Thea Helene ; Moustsen-Helms, Ida Rask ; Larsen, Signe Benzon ; Kjær, Trille Kristina ; Tjønneland, Anne ; Kjær, Susanne Krüger ; Johansen, Christoffer ; Gögenur, Ismail ; Dalton, Susanne Oksbjerg. / Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease. In: Acta Oncologica. 2023 ; Vol. 62, No. 7. pp. 728-736 .

Bibtex

@article{0195cf816055478f849ab3f2280ec0f4,
title = "Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease",
abstract = "Background: The risk of cardiovascular events in patients treated for colorectal cancer is debated due to diverging results in previous studies. Colorectal cancer and cardiovascular disease share several risk factors such as physical inactivity, obesity, and smoking. Information about confounding covariates and follow-up time are therefore essential to address the issue. This study aims to investigate the risk of new-onset cardiovascular events for patients with stage I-III colorectal cancer receiving elective surgery compared to a matched population. Material and Methods: Using a prospective cohort, we compared cardiovascular events among 876 patients treated with elective surgery for incident stage I-III colorectal cancer diagnosed between January 1st, 2001 and December 31st, 2016 to a cancer-free cohort matched by age, sex, and time since enrollment (N = 3504). Regression analyses were adjusted for lifestyle, cardiovascular risk factors, and comorbidity. Multivariable analyses were used to identify risk factors associated with cardiovascular events in the postoperative (<90 days of elective surgery) and long-term phase (>90 days after elective surgery). Results: After a median follow-up of 3.9 years, the hazard ratio (HR) for incident heart failure was 1.53 (95% CI 1.02–2.28) among patients operated for colorectal cancer. The postoperative risk of myocardial infarction or angina pectoris was associated with the use of lipid-lowering drugs. Long-term risks of cardiovascular events were ASA-score of III+IV and lipid-lowering drugs with HRs ranging from 2.20 to 15.8. Further, the use of antihypertensive drugs was associated with an HR of 2.09 (95% CI 1.06–4.13) for angina pectoris or acute myocardial infarction. Heart failure was associated with being overweight, diabetes, and anastomosis leakage. Conclusion: We observed an increased hazard of heart failure in patients operated on for stage I-III colorectal cancer compared to cancer-free comparisons. We identified several potential risk factors for cardiovascular events within and beyond 90 days of elective surgery.",
keywords = "cardiovascular disease, Colorectal cancer, late effects, surgery",
author = "Degett, {Thea Helene} and Moustsen-Helms, {Ida Rask} and Larsen, {Signe Benzon} and Kj{\ae}r, {Trille Kristina} and Anne Tj{\o}nneland and Kj{\ae}r, {Susanne Kr{\"u}ger} and Christoffer Johansen and Ismail G{\"o}genur and Dalton, {Susanne Oksbjerg}",
note = "Publisher Copyright: {\textcopyright} 2023 Acta Oncologica Foundation.",
year = "2023",
doi = "10.1080/0284186X.2023.2212844",
language = "English",
volume = "62",
pages = "728--736 ",
journal = "Acta Oncologica",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "7",

}

RIS

TY - JOUR

T1 - Cardiovascular events after elective colorectal cancer surgery in patients with stage I-III disease with no previous cardiovascular disease

AU - Degett, Thea Helene

AU - Moustsen-Helms, Ida Rask

AU - Larsen, Signe Benzon

AU - Kjær, Trille Kristina

AU - Tjønneland, Anne

AU - Kjær, Susanne Krüger

AU - Johansen, Christoffer

AU - Gögenur, Ismail

AU - Dalton, Susanne Oksbjerg

N1 - Publisher Copyright: © 2023 Acta Oncologica Foundation.

PY - 2023

Y1 - 2023

N2 - Background: The risk of cardiovascular events in patients treated for colorectal cancer is debated due to diverging results in previous studies. Colorectal cancer and cardiovascular disease share several risk factors such as physical inactivity, obesity, and smoking. Information about confounding covariates and follow-up time are therefore essential to address the issue. This study aims to investigate the risk of new-onset cardiovascular events for patients with stage I-III colorectal cancer receiving elective surgery compared to a matched population. Material and Methods: Using a prospective cohort, we compared cardiovascular events among 876 patients treated with elective surgery for incident stage I-III colorectal cancer diagnosed between January 1st, 2001 and December 31st, 2016 to a cancer-free cohort matched by age, sex, and time since enrollment (N = 3504). Regression analyses were adjusted for lifestyle, cardiovascular risk factors, and comorbidity. Multivariable analyses were used to identify risk factors associated with cardiovascular events in the postoperative (<90 days of elective surgery) and long-term phase (>90 days after elective surgery). Results: After a median follow-up of 3.9 years, the hazard ratio (HR) for incident heart failure was 1.53 (95% CI 1.02–2.28) among patients operated for colorectal cancer. The postoperative risk of myocardial infarction or angina pectoris was associated with the use of lipid-lowering drugs. Long-term risks of cardiovascular events were ASA-score of III+IV and lipid-lowering drugs with HRs ranging from 2.20 to 15.8. Further, the use of antihypertensive drugs was associated with an HR of 2.09 (95% CI 1.06–4.13) for angina pectoris or acute myocardial infarction. Heart failure was associated with being overweight, diabetes, and anastomosis leakage. Conclusion: We observed an increased hazard of heart failure in patients operated on for stage I-III colorectal cancer compared to cancer-free comparisons. We identified several potential risk factors for cardiovascular events within and beyond 90 days of elective surgery.

AB - Background: The risk of cardiovascular events in patients treated for colorectal cancer is debated due to diverging results in previous studies. Colorectal cancer and cardiovascular disease share several risk factors such as physical inactivity, obesity, and smoking. Information about confounding covariates and follow-up time are therefore essential to address the issue. This study aims to investigate the risk of new-onset cardiovascular events for patients with stage I-III colorectal cancer receiving elective surgery compared to a matched population. Material and Methods: Using a prospective cohort, we compared cardiovascular events among 876 patients treated with elective surgery for incident stage I-III colorectal cancer diagnosed between January 1st, 2001 and December 31st, 2016 to a cancer-free cohort matched by age, sex, and time since enrollment (N = 3504). Regression analyses were adjusted for lifestyle, cardiovascular risk factors, and comorbidity. Multivariable analyses were used to identify risk factors associated with cardiovascular events in the postoperative (<90 days of elective surgery) and long-term phase (>90 days after elective surgery). Results: After a median follow-up of 3.9 years, the hazard ratio (HR) for incident heart failure was 1.53 (95% CI 1.02–2.28) among patients operated for colorectal cancer. The postoperative risk of myocardial infarction or angina pectoris was associated with the use of lipid-lowering drugs. Long-term risks of cardiovascular events were ASA-score of III+IV and lipid-lowering drugs with HRs ranging from 2.20 to 15.8. Further, the use of antihypertensive drugs was associated with an HR of 2.09 (95% CI 1.06–4.13) for angina pectoris or acute myocardial infarction. Heart failure was associated with being overweight, diabetes, and anastomosis leakage. Conclusion: We observed an increased hazard of heart failure in patients operated on for stage I-III colorectal cancer compared to cancer-free comparisons. We identified several potential risk factors for cardiovascular events within and beyond 90 days of elective surgery.

KW - cardiovascular disease

KW - Colorectal cancer

KW - late effects

KW - surgery

U2 - 10.1080/0284186X.2023.2212844

DO - 10.1080/0284186X.2023.2212844

M3 - Journal article

C2 - 37262420

AN - SCOPUS:85161377040

VL - 62

SP - 728

EP - 736

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 7

ER -

ID: 356769781